These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases. Yoon JS; Lew H; Kim SJ; Lee SY Ophthalmology; 2008 Mar; 115(3):566-572.e2. PubMed ID: 17854900 [TBL] [Abstract][Full Text] [Related]
4. Primary placement of a hydroxyapatite-coated sleeve in bioceramic orbital implants. Liao SL; Shih MJ; Lin LL Am J Ophthalmol; 2005 Feb; 139(2):235-41. PubMed ID: 15733982 [TBL] [Abstract][Full Text] [Related]
5. Primary placement of hydroxyapatite-coated sleeves in bioceramic orbital implants. Jordan DR Am J Ophthalmol; 2005 Feb; 139(2):333-4. PubMed ID: 15733997 [No Abstract] [Full Text] [Related]
6. Prevention of exposure of porous orbital implants following enucleation. Naik MN; Mittal R; Murthy RK; Honavar SG Am J Ophthalmol; 2007 Jul; 144(1):161-2; author reply 162. PubMed ID: 17601454 [No Abstract] [Full Text] [Related]
9. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Su GW; Yen MT Ophthalmic Plast Reconstr Surg; 2004 Jul; 20(4):274-80. PubMed ID: 15266140 [TBL] [Abstract][Full Text] [Related]
10. Evisceration vs. enucleation. Goisis M; Guareschi M; Miglior S; Giannì AB Ophthalmology; 2007 Oct; 114(10):1960; author reply 1959-60. PubMed ID: 17908612 [No Abstract] [Full Text] [Related]